New 2026 C. auris Prevention Checklist — free download for infection control teams.Get it free
In-Bed Shower Systems for LTAC Facilities
Sustained CHG Decolonization for Complex, Long-Stay Patients
LTAC patients have among the highest rates of multidrug-resistant organism colonization in the US healthcare system. Sustained daily CHG bathing is essential for decolonization and Bed Shower Wib makes this practical for ventilated and device-dependent LTAC patients.
How Bed Shower™ Addresses Long-Term Acute Care
LTAC patients are the highest-risk population for C. auris colonization. The Gussin 2025 study (CID) was conducted in long-term care settings and directly supports the use of CHG bathing for C. auris decolonization in LTAC patients.
Real-World Outcomes
LTAC patients — many ventilator-dependent for weeks to months — required consistent CHG decolonization but were too medically fragile for transport to shower facilities. CHG wipe compliance was below 70%.
Bed Shower™ Wib™ was implemented as the standard bathing protocol for all LTAC patients, providing daily full-body CHG decolonization at bedside.
CHG bathing compliance increased to 97%. MRSA colonization rates decreased 44% over 12 months. Nursing time per bathing episode decreased by 18 minutes.
"Our patients are too sick to move. The Wib brings the shower to them — and our infection numbers have never been better."
Director of Nursing, LTAC Hospital
Common Questions About Long-Term Acute Care
Why are LTAC patients at particularly high risk for MDROs?
LTAC patients typically have prolonged hospital stays, multiple invasive devices, frequent antibiotic exposure, and complex underlying conditions, all major risk factors for MDRO acquisition and colonization. The high-contact caregiving required for these patients also increases transmission risk.
How does Bed Shower Wib support C. auris decolonization in LTAC?
Wib delivers full-body CHG bathing that achieves the 156 ug/mL or higher residual skin concentration required for 80% reduction in C. auris shedding (Gussin 2025). Daily use maintains decolonization status throughout the patient's LTAC stay.